# Case Report: Expanding the diagnostic spectrum of non-invasive prenatal testing to structural chromosomal abnormalities

**Authors:** Jong Chul Kim, Hyunjin Kim, HeeYeon Jang, Minyeon Go, Ji Eun Park, Chang Soo Ryu, Mi Uk Chin, Eun Hye Kim, Young Jin Lee, Sung Han Shim, Dong Hyun Cha

PMC · DOI: 10.3389/fgene.2026.1746287 · Frontiers in Genetics · 2026-02-17

## TL;DR

This case report shows how non-invasive prenatal testing can detect structural chromosomal abnormalities, which were confirmed through invasive diagnostic methods.

## Contribution

The study demonstrates the potential of NIPT to detect structural chromosomal abnormalities beyond numerical aneuploidies.

## Key findings

- NIPT results suggestive of sex chromosomal aneuploidies were confirmed as structural abnormalities through invasive testing.
- Three cases revealed structural abnormalities like X chromosome deletions/duplications and ring Y chromosome mosaicism.
- NIPT can contribute to the detection of structural chromosomal abnormalities when interpreted with caution.

## Abstract

Non-invasive prenatal testing (NIPT) has recently expanded to include sex chromosomal aneuploidies (SCAs) and copy number variations (CNVs), as well as the commonly screened trisomies (T21, T18, and T13). While the clinical utility of NIPT for detecting common fetal chromosomal aneuploidies is well established, its application in assessing structural chromosomal abnormalities (StrCAs) remains controversial, with limited consensus within the medical community. Furthermore, the accuracy of NIPT for detecting SCAs and CNVs is relatively lower than that for common trisomies. This study reports three cases in which NIPT results suggestive of SCAs were clarified by invasive diagnostic testing to represent underlying structural sex chromosome abnormalities. NIPT results suggestive of SCAs were validated through invasive diagnostic tests, including karyotyping, chromosomal microarray (CMA), quantitative fluorescence PCR (QF-PCR), and multiplex ligation-dependent probe amplification (MLPA). In the first case, the NIPT result suggestive of a monosomy X-like pattern reflected an underlying structural abnormality. Fetal chromosomal microarray (CMA) revealed a 3.6 Mb deletion involving the Xq27.3–q28 region and a 4.8 Mb duplication encompassing Xq28, with subsequent analysis confirming inactivation of the deleted X chromosome. In the second case, the NIPT result suggesting monosomy X with a low Y chromosome fraction (1.46%) resembled a vanishing twin pattern but was ultimately explained by mosaicism involving a ring Y chromosome (46,X,r(Y)/45,X). CMA revealed a 7.4 Mb duplication of Yp11.31–p11.2 and a 15 Mb deletion of Yq11.21–q11.23, confirming mosaic ring Y formation. In the third case, the NIPT finding suggestive of XYY with Xp22.33–p22.2 deletion was clarified by confirmatory testing as a maternal sex chromosome translocation, 46,X,der(X)t (X; Y) (p22.2; q11.222), detected in the mother with short stature but no other clinical features. In conclusion, these three NIPT findings initially interpreted as SCAs were clarified by confirmatory invasive diagnostics, illustrating the complexity of interpreting results associated with StrCAs. These findings support the potential of NIPT to extend beyond numerical aneuploidy screening and contribute to the detection of structural chromosomal abnormalities.

## Full-text entities

- **Genes:** AR (androgen receptor) [NCBI Gene 367] {aka AIS, AR8, DHTR, HPCX3, HUMARA, HYSP1}, VAMP7 (vesicle associated membrane protein 7) [NCBI Gene 6845] {aka SYBL1, TI-VAMP, TIVAMP, VAMP-7}, F2RL1 (F2R like trypsin receptor 1) [NCBI Gene 2150] {aka GPR11, PAR2}, FMR1 (fragile X messenger ribonucleoprotein 1) [NCBI Gene 2332] {aka FMRP, FRAXA, POF, POF1}, SHOX (SHOX homeobox) [NCBI Gene 6473] {aka GCFX, PHOG, SHOX1, SHOXY, SS}, AZF [NCBI Gene 560], MECP2 (methyl-CpG binding protein 2) [NCBI Gene 4204] {aka AUTSX3, MRX16, MRX79, MRXS13, MRXSL, PPMX}, AFF2 (ALF transcription elongation factor 2) [NCBI Gene 2334] {aka FMR2, FMR2P, FRAXE, MRX2, OX19, XLID109}
- **Diseases:** 47,XXX (MESH:C535318), X-chromosome loss (MESH:D040181), 45,X (OMIM:616669), trisomies (MESH:D014314), PWS (MESH:D011218), 47,XXY (MESH:D007713), anxiety (MESH:D001007), Sex chromosome abnormalities (MESH:D012729), 22q11.22 (MESH:D058165), DGS (MESH:D004062), 47,XYY (MESH:C535317), maternal malignancy (MESH:D009369), StrCAs (MESH:D002869), X-linked intellectual disability (MESH:D008607), CNV (MESH:D000092342), short stature (MESH:D006130), CDC (MESH:D003410), cognitive/behavioral impairment (MESH:D003072), aneuploidies (MESH:D000782), CMA (MESH:D025063), neurodevelopmental deficits (MESH:D009461), SCAs (MESH:D025064), Monosomy X (MESH:D014424), developmental delay (MESH:D002658), 48,XXXX (MESH:C536502), trisomies 21, 18, and 13 (MESH:D000073839), SCA (MESH:C565772), P245 Microdeletion Syndromes-1A (OMIM:613675), 49,XXXXX (MESH:C535319), monosomy (MESH:D009006), fetal abnormalities (MESH:D005315), Structural abnormalities (MESH:C566527), cutaneous abnormalities (MESH:D018366), underweight (MESH:D013851), miscarriage (MESH:D000022)
- **Chemicals:** BIO-AMF  medium (-), biotin (MESH:D001710)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12952721/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12952721/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12952721/full.md

---
Source: https://tomesphere.com/paper/PMC12952721